BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3884399)

  • 1. [Trials on bulla induction by antibodies from bullous pemphigoid patients in vivo and in vitro].
    Lohrisch I; Noack H; Haustein UF; Sparmann G; Koch J
    Dermatol Monatsschr; 1985; 171(2):106-12. PubMed ID: 3884399
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transitory immune-complex nephritis in bullous pemphigoid].
    Lohrisch I; Achenbach H; Haustein UF; Herrmann K
    Dermatol Monatsschr; 1982 Jul; 168(7):477-82. PubMed ID: 6215269
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the autoimmune pathogenesis of bullous pemphigoid. Review of the literature and our results (author's transl)].
    Haustein UF; Lohrisch I; Herrmann K
    Dermatol Monatsschr; 1980 Sep; 166(9):585-98. PubMed ID: 7004925
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding cells of bullous pemphigoid antibodies to basal cells.
    Krasny S; Beutner EH; Kumar V; Jablonska S; Chorzelski TP
    J Invest Dermatol; 1981 Aug; 77(2):251. PubMed ID: 7024427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
    Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
    Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
    [No Abstract]   [Full Text] [Related]  

  • 6. Localized pemphigoid: a case report showing in situ deposition as well as presence in serum of IgG and IgA anti-basement membrane zone antibodies.
    Sugihara K; Dekio S; Tohgi K; Jidoi J
    J Dermatol; 1987 Feb; 14(1):73-6. PubMed ID: 3301954
    [No Abstract]   [Full Text] [Related]  

  • 7. An immunological study of patients with bullous pemphigoid.
    Hovmark A; Asbrink E
    Acta Derm Venereol; 1982; 62(3):201-4. PubMed ID: 6179358
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 9. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papules with basement membrane zone antibodies preceding bullous pemphigoid.
    Lorette G; Fetissoff F
    Arch Dermatol; 1982 Nov; 118(11):878-9. PubMed ID: 6753763
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving concept of IgA linear dermatosis.
    Chorzelski T; Jablonska S
    Semin Dermatol; 1988 Sep; 7(3):225-32. PubMed ID: 3153448
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid.
    Yamasaki Y; Nishikawa T
    Acta Derm Venereol; 1983; 63(6):501-6. PubMed ID: 6198839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psoriasis and bullous pemphigoid].
    Bork K
    Hautarzt; 1987 Jun; 38(6):348-51. PubMed ID: 3308771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgE levels in patients with bullous pemphigoid.
    Nieboer C
    Acta Derm Venereol; 1985; 65(3):273-4. PubMed ID: 2411092
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of pemphigoid antibodies].
    Kühn G; Jarzabek-Chorzelska M; Kolacinska-Strasz Z
    Dermatol Monatsschr; 1988; 174(2):99-102. PubMed ID: 3286306
    [No Abstract]   [Full Text] [Related]  

  • 18. Localized bullous pemphigoid with negative immunofluorescence.
    Silber JG; Brody N
    Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of bullous pemphigoid and transitional cell carcinoma of the bladder. Demonstration of a circulating factor reactive with basement membrane zone of skin and of bladder carcinoma.
    Tanaka T; Ogino A; Ogura K; Nakagawa K
    Arch Dermatol; 1983 Aug; 119(8):704-5. PubMed ID: 6347090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Induction of pemphigoid lesions in neonatal mice].
    Mitsuhashi Y; Takahashi M; Sawamura D; Yamatani S; Hashimoto I; Katabira Y
    Nihon Hifuka Gakkai Zasshi; 1985 May; 95(6):675-80. PubMed ID: 3897671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.